|
|
"In connection with many of our large strategic transactions, Goldman Sachs has played a very important role in helping us achieve our position as the world's leading medical technology company. In fact, Goldman Sachs' part in helping to develop a creative financing solution was critical to our recent successful acquisition of MiniMed and Medical Research Group (MRG). By issuing the convertible debt securities to finance the acquisition, we were able to access a new pool of low-cost capital that enhanced the economics and ultimate closing of the deal. This was the largest-ever convertible transaction in the biotechnology industry. The results have been excellent."
Art Collins
President and Chief Executive Officer
Medtronic, Inc.
|
|